Corcept Therapeutics reported $28.16M in Trade Debtors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 68.89M 5.41M
Ani Pharmaceuticals ANIP:US $ 150.41M 16.8M
Ardelyx ARDX:US $ 5.62M 1.23M
Aurora Cannabis Inc ACB:CN 47.05M 8.58M
Biomarin Pharmaceutical BMRN:US $ 466.51M 36.36M
Bristol Myers Squibb BMY:US $ 12540M 4029M
Canopy Growth Corp WEED:CN C$ 96.63M 183K
Corcept Therapeutics CORT:US $ 28.16M 0.99M
Depomed DEPO:US $ 49.23M 0.31M
Eleven Biotherapeutics EBIO:US 2.05M 22.44M
Eli Lilly And LLY:US $ 7672.4M 133.3M
Esperion Therapeutics ESPR:US 27.84M 2.73M
Knight Therapeutics Inc GUD:CN C$ 92.02M 10.67M
Lannett LCI:US $ 93.03M 8.18M
Nektar Therapeutics NKTR:US $ 10.01M 20.21M
Novartis NOVN:VX 8.91B 232M
Novartis NVS:US $ 8910M 232M
Omeros OMER:US $ 58.27M 2.09M
Pacira Pharmaceuticals PCRX:US $ 91.1M 1M
Supernus Pharmaceuticals SUPN:US $ 158.06M 12.91M